do glp 1 drugs cause fatigue from GLP-1 Injections GLP-1a: Going beyond Traditional Use

Piening A, Ebert E, Gottlieb C, Khojandi N, Kuehm LM, Hoft SG, et al

In this study, participants taking orforglipron experienced an average A1C reduction of 2.1% and an average weight loss of 10.1 kilograms at 26 weeks, which was significantly greater than those in the placebo and dulaglutide groups

The decision about whether any compounded GLP-1 medication is appropriate for your specific situation rests with your evaluating clinician

No association between semaglutide and suicidal thoughts Semaglutide has been shown to provide weight loss and cardiovascular disease benefits in patients with overweight and obesity, although obesity has been tied to depressive and other psychiatric conditions, Thomas A

For people without insurance coverage, compounded semaglutide is often a financially accessible option

p = 0.065